Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol in Advanced Androgen-Insensitive Prostate Cancer
NCT00634582Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2009
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of paricalcitol in prostate cancer (PCa), sponsored by Wake Forest University Health Sciences. Started Jan 2009; status: terminated.
02
Drugs
paricalcitol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00634582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634582.